Kenneth B Lee Jr Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Kenneth B Lee Jr is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 68,863 shares of BCRX, which is worth approximately $500,634. The most recent transaction as insider was on Jun 13, 2023, when has been sold 16,745 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.9K
0% 3M change
0% 12M change
Total Value Held $500,634

KENNETH B LEE Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2023
BUY
Grant, award, or other acquisition
-
16,745 Added 19.56%
68,863 Common Stock
Jan 31 2023
BUY
Exercise of conversion of derivative security
$25,650 $1.71 p/Share
15,000 Added 22.35%
52,118 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
12,866 Added 25.74%
37,118 Common Stock
Sep 13 2021
SELL
Open market or private sale
$92,100 $15.35 p/Share
6,000 Reduced 19.83%
24,252 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$48,300 $3.22 p/Share
15,000 Added 33.15%
30,252 Common Stock

Also insider at

EYEN
EYENOVIA, INC. Healthcare
KBL

Kenneth B Lee Jr

Director
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX